Literature DB >> 25210095

Temporal trends in the population attributable risk for cardiovascular disease: the Atherosclerosis Risk in Communities Study.

Susan Cheng1, Brian Claggett2, Andrew W Correia2, Amil M Shah2, Deepak K Gupta2, Hicham Skali2, Hanyu Ni2, Wayne D Rosamond2, Gerardo Heiss2, Aaron R Folsom2, Josef Coresh2, Scott D Solomon2.   

Abstract

BACKGROUND: The extent to which the relative contributions of traditional cardiovascular risk factors to incident cardiovascular disease (CVD) may have changed over time remains unclear. METHODS AND
RESULTS: We studied 13 541 participants (56% women, 26% black) in the Atherosclerosis Risk in Communities Study, aged 52 to 66 years and free of CVD at exams in 1987 through 1989, 1990 through 1992, 1993 through 1995, or 1996 through 1998. At each examination, we estimated the population attributable risks (PAR) of traditional risk factors (hypertension, diabetes mellitus, obesity, hypercholesterolemia, and smoking) for the 10-year incidence of CVD. Overall, the PAR of all risk factors combined appeared to decrease from the late 1980s to the late 1990s (0.58 to 0.53). The combined PAR was higher in women than men in 1987 through 1989 (0.68 versus 0.51, P<0.001) but not by the late 1990s (0.58 versus 0.48, P=0.08). The combined PAR was higher in blacks than whites in the late 1980s (0.67 versus 0.57, P=0.049), and this difference was more pronounced by the late 1990s (0.67 versus 0.48, P=0.002). By the late 1990s, the PAR of hypertension had become higher in women than men (P=0.02) and also appeared higher in blacks than whites (P=0.08). By the late 1990s, the PAR of diabetes mellitus remained higher in women than men (P<0.0001) and in blacks than whites (P<0.0001).
CONCLUSIONS: The contribution to CVD of all traditional risk factors combined is greater in blacks than whites, and this difference may be increasing. The contributions of hypertension and diabetes mellitus remain especially high, in women as well as blacks. These findings underscore the continued need for individual as well as population approaches to CVD risk factor modification.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  cardiovascular diseases; ethnicity; gender; prevention; race; risk factors

Mesh:

Year:  2014        PMID: 25210095      PMCID: PMC4161984          DOI: 10.1161/CIRCULATIONAHA.113.008506

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  47 in total

1.  US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008.

Authors:  Brent M Egan; Yumin Zhao; R Neal Axon
Journal:  JAMA       Date:  2010-05-26       Impact factor: 56.272

2.  Absolute and attributable risks of cardiovascular disease incidence in relation to optimal and borderline risk factors: comparison of African American with white subjects--Atherosclerosis Risk in Communities Study.

Authors:  Atsushi Hozawa; Aaron R Folsom; A Richey Sharrett; Lloyd E Chambless
Journal:  Arch Intern Med       Date:  2007-03-26

Review 3.  Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond.

Authors:  Donald M Lloyd-Jones; Yuling Hong; Darwin Labarthe; Dariush Mozaffarian; Lawrence J Appel; Linda Van Horn; Kurt Greenlund; Stephen Daniels; Graham Nichol; Gordon F Tomaselli; Donna K Arnett; Gregg C Fonarow; P Michael Ho; Michael S Lauer; Frederick A Masoudi; Rose Marie Robertson; Véronique Roger; Lee H Schwamm; Paul Sorlie; Clyde W Yancy; Wayne D Rosamond
Journal:  Circulation       Date:  2010-01-20       Impact factor: 29.690

4.  Recent declines in hospitalizations for acute myocardial infarction for Medicare fee-for-service beneficiaries: progress and continuing challenges.

Authors:  Jersey Chen; Sharon-Lise T Normand; Yun Wang; Elizabeth E Drye; Geoffrey C Schreiner; Harlan M Krumholz
Journal:  Circulation       Date:  2010-03-08       Impact factor: 29.690

5.  Population trends in the incidence and outcomes of acute myocardial infarction.

Authors:  Robert W Yeh; Stephen Sidney; Malini Chandra; Michael Sorel; Joseph V Selby; Alan S Go
Journal:  N Engl J Med       Date:  2010-06-10       Impact factor: 91.245

6.  Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004.

Authors:  Kwok Leung Ong; Bernard M Y Cheung; Yu Bun Man; Chu Pak Lau; Karen S L Lam
Journal:  Hypertension       Date:  2006-12-11       Impact factor: 10.190

7.  Mortality trends in men and women with diabetes, 1971 to 2000.

Authors:  Edward W Gregg; Qiuping Gu; Yiling J Cheng; K M Venkat Narayan; Catherine C Cowie
Journal:  Ann Intern Med       Date:  2007-06-18       Impact factor: 25.391

8.  Prevalence and trends in obesity among US adults, 1999-2008.

Authors:  Katherine M Flegal; Margaret D Carroll; Cynthia L Ogden; Lester R Curtin
Journal:  JAMA       Date:  2010-01-13       Impact factor: 56.272

9.  Risk factors for myocardial infarction in women and men: insights from the INTERHEART study.

Authors:  Sonia S Anand; Shofiqul Islam; Annika Rosengren; Maria Grazia Franzosi; Krisela Steyn; Afzal Hussein Yusufali; Matyas Keltai; Rafael Diaz; Sumathy Rangarajan; Salim Yusuf
Journal:  Eur Heart J       Date:  2008-03-10       Impact factor: 29.983

10.  Explaining the decrease in U.S. deaths from coronary disease, 1980-2000.

Authors:  Earl S Ford; Umed A Ajani; Janet B Croft; Julia A Critchley; Darwin R Labarthe; Thomas E Kottke; Wayne H Giles; Simon Capewell
Journal:  N Engl J Med       Date:  2007-06-07       Impact factor: 91.245

View more
  52 in total

Review 1.  Going Beyond the Guidelines in Individualising the Use of Antihypertensive Drugs in Older Patients.

Authors:  Ian A Scott; Sarah N Hilmer; David G Le Couteur
Journal:  Drugs Aging       Date:  2019-08       Impact factor: 3.923

2.  Pregnancy as a Window to Cardiovascular Disease Risk: How Will We Know?

Authors:  Janet M Catov
Journal:  J Womens Health (Larchmt)       Date:  2015-06-30       Impact factor: 2.681

3.  Ethnicity, Obesity and Emotional Factors Associated With Gestational Hypertension.

Authors:  Rafaela Cristina Franco; Caroline Ronchini Ferreira; Camilla Ribeiro Vieira; Roberta Ribeiro Silva
Journal:  J Community Health       Date:  2015-10

4.  Association of Resting Heart Rate and Temporal Changes in Heart Rate With Outcomes in Participants of the Atherosclerosis Risk in Communities Study.

Authors:  Ali Vazir; Brian Claggett; Susan Cheng; Hicham Skali; Amil Shah; David Agulair; Christie Mitchell Ballantyne; Orly Vardeny; Scott D Solomon
Journal:  JAMA Cardiol       Date:  2018-03-01       Impact factor: 14.676

5.  The 2017 high blood pressure clinical practice guideline: The old and the new.

Authors:  Arthur Z Schwartzbard; Jonathan D Newman; Howard S Weintraub; Seth J Baum
Journal:  Clin Cardiol       Date:  2018-03-25       Impact factor: 2.882

6.  Pregnancy as a Window to Racial Disparities in Hypertension.

Authors:  Claire E Margerison; Janet Catov; Claudia Holzman
Journal:  J Womens Health (Larchmt)       Date:  2018-06-21       Impact factor: 2.681

Review 7.  Hypertensive Disorders of Pregnancy and Cardiovascular Diseases: Current Knowledge and Future Directions.

Authors:  Thais Coutinho; Olabimpe Lamai; Kara Nerenberg
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-06-19

8.  Recognition and Management of Elevated Blood Pressure in Pediatric Patients: Challenges and Disparities in Community Health Centers.

Authors:  Rikki L Ward; Jessica M Robbins; Rebecca N Haden; Brittany J Benson; Issy C Esangbedo
Journal:  J Community Health       Date:  2016-04

9.  Does Gender Influence the Relationship Between High Blood Pressure and Dementia? Highlighting Areas for Further Investigation.

Authors:  Anna E Blanken; Daniel A Nation
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

Review 10.  Understanding the Importance of Race/Ethnicity in the Care of the Hypertensive Patient.

Authors:  Keith C Ferdinand; Samar A Nasser
Journal:  Curr Hypertens Rep       Date:  2015-03       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.